SCHOENBERG MARK (Chief Medical Officer) sold 6.9% of their position (10K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $300.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/11/2026ACC: 0001437749-26-016104
Officer· Chief Medical Officer
Since Jan 2019
-10K
Net shares
Net seller
$300.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10K
Price / share
$30.00
Trade value
$300K
% of position
6.9%
5/8/2026
144.99K→134.99K
Total
Net shares
−10K
Net value
-$300K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/8/2026 | S · Sale | −10K | $30.00 | $300K | 6.9% | 144.99K | 134.99K |
| Total | −10K | -$300K | ||||||
Derivative Transactions0
No derivative transactions reported